Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma
Authors:
- Souichi YanamotoSYSouichi Yanamoto
- Goro KawasakiGKGoro Kawasaki
- Izumi YoshitomiIYIzumi Yoshitomi
- Akio MizunoAMAkio Mizuno
- 1 February 2003
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 190 (2) , 233-243
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Apoptosis, angiogenesis and proliferation: trifunctional measure of tumour response to radiotherapy for oral cancerOral Oncology, 2001
- Role of pretherapeutic biomarkers in predicting postoperative radiotherapy response in patients with advanced squamous cell carcinomaInternational Journal of Radiation Biology, 2001
- Alterations of p53, pRb, cyclin D1 and cdk4 in human oral and pharyngeal squamous cell carcinomasOral Oncology, 2000
- A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damageNature, 2000
- Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypesInternational Journal of Cancer, 2000
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- Independent predictors of response and disease-free survival in oral cancer treated with radical radiation therapyCancer, 1992
- A genetic model for colorectal tumorigenesisCell, 1990
- Many Gene Changes Found in CancerScience, 1989
- Predictive Assays of Tumor RadiocurabilityAmerican Journal of Clinical Oncology, 1988